JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE) ›› 2021, Vol. 41 ›› Issue (7): 972-976.doi: 10.3969/j.issn.1674-8115.2021.07.021
• Review • Previous Articles
Hong-yan XUAN1,2(), Li-hua WANG1, Hua-fang LI1,3,4()
Online:
2021-07-28
Published:
2021-08-03
Contact:
Hua-fang LI
E-mail:ameliexuan@163.com;lhlh_5@163.com
Supported by:
CLC Number:
Hong-yan XUAN, Li-hua WANG, Hua-fang LI. Review of the factors influencing bone metabolism in schizophrenia[J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(7): 972-976.
Add to citation manager EndNote|Ris|BibTeX
URL: https://xuebao.shsmu.edu.cn/EN/10.3969/j.issn.1674-8115.2021.07.021
1 | Stubbs B, De Hert M, Sepehry AA, et al. A meta-analysis of prevalence estimates and moderators of low bone mass in people with schizophrenia[J]. Acta Psychiatr Scand, 2014, 130(6): 470-486. |
2 | Cui JY, Liu HQ, Shao J, et al. Prevalence, risk factors and clinical characteristics of osteoporosis in Chinese inpatients with schizophrenia[J]. Schizophr Res, 2018, 195: 488-494. |
3 | Tseng PT, Chen YW, Yeh PY, et al. Bone mineral density in schizophrenia: an update of current meta-analysis and literature review under guideline of PRISMA[J]. Medicine (Baltimore), 2015, 94(47): e1967. |
4 | Partti K, Heliövaara M, Impivaara O, et al. Skeletal status in psychotic disorders: a population-based study[J]. Psychosom Med, 2010, 72(9): 933-940. |
5 | 冒雷明, 周春英, 胡亚兰, 等. 首发精神分裂症患者骨密度检测及影响因素分析[J]. 临床心身疾病杂志, 2017, 23(6): 168-170. |
6 | Mayne PE, Burne THJ. Vitamin D in synaptic plasticity, cognitive function, and neuropsychiatric illness[J]. Trends Neurosci, 2019, 42(4): 293-306. |
7 | Berg AO, Jørgensen KN, Nerhus M, et al. Vitamin D levels, brain volume, and genetic architecture in patients with psychosis[J]. PLoS One, 2018, 13(8): e0200250. |
8 | Allott K, McGorry PD, Yuen HP, et al. The vitamins in psychosis study: a randomized, double-blind, placebo-controlled trial of the effects of vitamins B12, B6, and folic acid on symptoms and neurocognition in first-episode psychosis[J]. Biol Psychiatry, 2019, 86(1): 35-44. |
9 | Hubbard DB, Miller BJ. Meta-analysis of blood cortisol levels in individuals with first-episode psychosis[J]. Psychoneuroendocrinology, 2019, 104: 269-275. |
10 | Gyllenberg D, Sourander A, Surcel HM, et al. Hypothyroxinemia during gestation and offspring schizophrenia in a national birth cohort[J]. Biol Psychiatry, 2016, 79(12): 962-970. |
11 | Kočovská E, Gaughran F, Krivoy A, et al. Vitamin-D deficiency as a potential environmental risk factor in multiple sclerosis, schizophrenia, and autism[J]. Front Psychiatry, 2017, 8: 47. |
12 | van der Leeuw C, de Witte LD, Stellinga A, et al. Vitamin D concentration and psychotic disorder: associations with disease status, clinical variables and urbanicity[J]. Psychol Med, 2020, 50(10): 1680-1686. |
13 | Valipour G, Saneei P, Esmaillzadeh A. Serum vitamin D levels in relation to schizophrenia: a systematic review and meta-analysis of observational studies[J]. J Clin Endocrinol Metab, 2014, 99(10): 3863-3872. |
14 | Taylor AE, Burgess S, Ware JJ, et al. Investigating causality in the association between 25(OH)D and schizophrenia[J]. Sci Rep, 2016, 6: 26496. |
15 | Crews M, Lally J, Gardner-Sood P, et al. Vitamin D deficiency in first episode psychosis: a case-control study[J]. Schizophr Res, 2013, 150(2/3): 533-537. |
16 | Lally J, Ajnakina O, Singh N, et al. Vitamin D and clinical symptoms in First Episode Psychosis (FEP): a prospective cohort study[J]. Schizophr Res, 2019, 204: 381-388. |
17 | Muscogiuri G, Altieri B, de Angelis C, et al. Shedding new light on female fertility: the role of vitamin D[J]. Rev Endocr Metab Disord, 2017, 18(3): 273-283. |
18 | Levine J, Stahl Z, Sela BA, et al. Homocysteine-reducing strategies improve symptoms in chronic schizophrenic patients with hyperhomocysteinemia[J]. Biol Psychiatry, 2006, 60(3): 265-269. |
19 | Petronijević ND, Radonjić NV, Ivković MD, et al. Plasma homocysteine levels in young male patients in the exacerbation and remission phase of schizophrenia[J]. Prog Neuropsychopharmacol Biol Psychiatry, 2008, 32(8): 1921-1926. |
20 | Weber DR, Coughlin C, Brodsky JL, et al. Low bone mineral density is a common finding in patients with homocystinuria[J]. Mol Genet Metab, 2016, 117(3): 351-354. |
21 | Cherian K, Schatzberg AF, Keller J. HPA axis in psychotic major depression and schizophrenia spectrum disorders: cortisol, clinical symptomatology, and cognition[J]. Schizophr Res, 2019, 213: 72-79. |
22 | Girshkin L, Matheson SL, Shepherd AM, et al. Morning cortisol levels in schizophrenia and bipolar disorder: a meta-analysis[J]. Psychoneuroen-docrinology, 2014, 49: 187-206. |
23 | Hardy RS, Zhou H, Seibel MJ, et al. Glucocorticoids and bone: consequences of endogenous and exogenous excess and replacement therapy[J]. Endocr Rev, 2018, 39(5): 519-548. |
24 | Noda M. Possible role of glial cells in the relationship between thyroid dysfunction and mental disorders[J]. Front Cell Neurosci, 2015, 9: 194. |
25 | Sharif K, Tiosano S, Watad A, et al. The link between schizophrenia and hypothyroidism: a population-based study[J]. Immunol Res, 2018, 66(6): 663-667. |
26 | Williams GR, Bassett JHD. Thyroid diseases and bone health[J]. J Endocrinol Invest, 2018, 41(1): 99-109. |
27 | Nikolić T, Petronijević M, Sopta J, et al. Haloperidol affects bones while clozapine alters metabolic parameters-sex specific effects in rats perinatally treated with phencyclidine[J]. BMC Pharmacol Toxicol, 2017, 18(1): 65. |
28 | Zhang BB, Deng L, Wu HS, et al. Relationship between long-term use of a typical antipsychotic medication by Chinese schizophrenia patients and the bone turnover markers serum osteocalcin and β-CrossLaps[J]. Schizophr Res, 2016, 176(2/3): 259-263. |
29 | Bolton JM, Morin SN, Majumdar SR, et al. Association of mental disorders and related medication use with risk for major osteoporotic fractures[J]. JAMA Psychiatry, 2017, 74(6): 641-648. |
30 | Inder WJ, Castle D. Antipsychotic-induced hyperprolactinaemia[J]. Aust N Z J Psychiatry, 2011, 45(10): 830-837. |
31 | Bernard V, Young J, Binart N. Prolactin-a pleiotropic factor in health and disease[J]. Nat Rev Endocrinol, 2019, 15(6): 356-365. |
32 | Liang MN, Zhang BB, Deng L, et al. Effects of olanzapine on bone mineral density, glucose, and lipid metabolism in schizophrenia patients[J]. Int J Endocrinol, 2019, 2019: 1312804. |
33 | Gomez L, Stubbs B, Shirazi A, et al. Lower bone mineral density at the hip and lumbar spine in people with psychosis versus controls: a comprehensive review and skeletal site-specific meta-analysis[J]. Curr Osteoporos Rep, 2016, 14(6): 249-259. |
34 | 李艳歌, 于文娟, 沈一峰, 等. 抗精神病药治疗精神分裂症导致催乳素水平差异的机制[J]. 上海交通大学学报(医学版), 2018, 38(7): 797-800. |
35 | Wang MX, Hou RH, Jian J, et al. Effects of antipsychotics on bone mineral density and prolactin levels in patients with schizophrenia: a 12-month prospective study[J]. Hum Psychopharmacol, 2014, 29(2): 183-189. |
36 | Meaney AM, O'Keane V. Bone mineral density changes over a year in young females with schizophrenia: relationship to medication and endocrine variables[J]. Schizophr Res, 2007, 93(1-3): 136-143. |
37 | Lodhi RJ, Masand S, Malik A, et al. Changes in biomarkers of bone turnover in an aripiprazole add-on or switching study[J]. Schizophr Res, 2016, 170(2/3): 245-251. |
38 | Abraham G, Paing WW, Kaminski J, et al. Effects of elevated serum prolactin on bone mineral density and bone metabolism in female patients with schizophrenia: a prospective study[J]. Am J Psychiatry, 2003, 160(9): 1618-1620. |
39 | van der Leeuw C, Peeters S, Domen P, et al. Bone mineral density as a marker of cumulative estrogen exposure in psychotic disorder: a 3 year follow-up study[J]. PLoS One, 2015, 10(8): e0136320. |
40 | Clapham E, Bodén R, Reutfors J, et al. Exposure to risperidone versus other antipsychotics and risk of osteoporosis-related fractures: a population-based study[J]. Acta Psychiatr Scand, 2020, 141(1): 74-83. |
41 | Park YM, Lee SH, Lee BH, et al. Prolactin and macroprolactin levels in psychiatric patients receiving atypical antipsychotics: a preliminary study[J]. Psychiatry Res, 2016, 239: 184-189. |
42 | Kim HY, Choe JW, Kim HK, et al. Negative association between metabolic syndrome and bone mineral density in Koreans, especially in men[J]. Calcif Tissue Int, 2010, 86(5): 350-358. |
43 | Lin CH, Lin CY, Wang HS, et al. Long-term use of clozapine is protective for bone density in patients with schizophrenia[J]. Sci Rep, 2019, 9(1): 3895. |
44 | Qiu J, Gong HX, Wang BX, et al. The use of clozapine is protective for low bone mineral density induced by prolactin-raising antipsychotics in inpatients with schizophrenia[J]. Arch Osteoporos, 2020, 15(1): 98. |
45 | Faulkner G, Cohn T, Remington G. Validation of a physical activity assessment tool for individuals with schizophrenia[J]. Schizophr Res, 2006, 82(2/3): 225-231. |
46 | Mallet J, Le Strat Y, Schürhoff F, et al. Cigarette smoking and schizophrenia: a specific clinical and therapeutic profile? Results from the FACE-Schizophrenia cohort[J]. Prog Neuropsychopharmacol Biol Psychiatry, 2017, 79(Pt B): 332-339. |
47 | Volkow ND. Substance use disorders in schizophrenia: clinical implications of comorbidity[J]. Schizophr Bull, 2009, 35(3): 469-472. |
48 | Roick C, Fritz-Wieacker A, Matschinger H, et al. Health habits of patients with schizophrenia[J]. Soc Psychiatry Psychiatr Epidemiol, 2007, 42(4): 268-276. |
49 | 张智海, 刘忠厚, 李娜, 等. 中国人骨质疏松症诊断标准专家共识(第三稿·2014版)[J]. 中国骨质疏松杂志, 2014, 20(9): 1007-1010. |
50 | 中华医学会, 中华医学会杂志社, 中华医学会全科医学分会, 等. 原发性骨质疏松症基层诊疗指南(2019年)[J]. 中华全科医师杂志, 2020, 19(4): 304-315. |
[1] | Bing-fu SONG, Bin-bin Ding, Xiao-li ZHANG, Li-yun YAO. Observation of therapeutic efficacy of metformin on glucose dysregulation and dyslipidaemia induced by quetiapine in patients with schizophrenia [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(6): 776-780. |
[2] | Guo-qin HU, Cheng-qing YANG, Qin-yu LÜ, Jing ZHAO, Ming-huan ZHU, Zheng-hui YI, Xin-hai DAI. Effects of computerized cognitive correction therapy on cognitive function of schizophrenia [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(5): 622-627. |
[3] | Miao-miao CAI, Yan-hong GAO. Research progress of osteosarcopenia [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(5): 678-683. |
[4] | Hong YANG, Xin-xin HUANG, Chao LIU, Qing-song LIANG, Hua YANG, Jian-biao ZHANG, Jian XU, Ying-yi WANG, Hai-su WU, Qin-yu LÜ, Zheng-hui YI. Association study of synaptotagmin 2 gene polymorphisms with schizophrenia in Chinese Han population [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(1): 16-22. |
[5] | Guo-qin HU, Qin-yu LÜ, Jing ZHAO, Ming-huan ZHU, Shun-ying YU, Zheng-hui YI, Jian CHEN. Association study of non-coding variant of NOS1AP gene with schizophrenia [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(1): 29-34. |
[6] | LUAN Feng-huan, YE Hui-ling, XU Lu, FAN Qing, SONG Li-sheng. Application of social skills training to outpatients with schizophrenia [J]. , 2020, 40(4): 500-. |
[7] | WANG Feng-wei, SHEN Qiu-ming, SHI Yue, ZHANG Shu-xian, WANG Hu-wen, CHANG Rui-jie, YANG Ying-hua, WAN He-ping, SHEN Tian, CAI Yong. Analysis on the prevention of osteoporosis in middle-aged and elderly residents of Shanghai community [J]. , 2020, 40(4): 525-. |
[8] | LI Na, AN Yu, ZHANG Yong-lu, DING Zhi-jie, WU Bai-lin, LAN Xiao-ping. Association analysis of single nucleotide polymorphisms in the promoter region of GAD1 and GABRB3 with schizophrenia in Chinese Han population [J]. , 2020, 40(3): 310-. |
[9] | LI Xuan, XIANG Qiong, ZHAN Yan, ZHU Dian-ming, ZHUO Kai-ming, WANG Ya, CHEN Hai-ying, LIU Deng-tang. Psychological mechanism of event-based prospective memory deficit in patients with first-episode schizophrenia [J]. , 2020, 40(2): 208-. |
[10] | WEN Wan-jun1, CHEN Ye1, QIN Zong-hou1, LÜ Wang-qiang2, TANG Wei3, LU Wei-hong4, FAN Wei-xing2, ZHANG Chen4. Relationship between serum interleukin-6 level and depressive symptoms in schizophrenia [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2020, 40(12): 1618-1620. |
[11] | REN Yan-yan, LÜ Qin-yu, YANG Wei-li, WANG Zhen. Correlation between childhood trauma and schizophrenia symptoms [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2020, 40(12): 1641-1645. |
[12] | XIANG Si-ying, LI Ning-ning, XU Yi-feng#, CHEN Jian-hua#. Advances in DNA methylation mechanism of antipsychotic-induced metabolic syndrome [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2020, 40(12): 1656-1659. |
[13] | CUI Ya-qi, BAI Yu-bing, XU Yi-chen, TAN Xin-chen, LI Meng-ying, JIA Hao. Research progress of adipose-derived mesenchymal stem cell and its extracellular vesicles in osteogenesis [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2020, 40(12): 1672-1676. |
[14] | WANG Ying-chan, WANG Ji-jun. Research progress of effect of antipsychotics on resting brain function in patients with schizophrenia [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2020, 40(11): 1515-1518. |
[15] | HUANG Yan, ZHANG Xian-gao, LIN Heng, CHENG Shu-ying. Meta-analysis of effect and safety of repetitive transcranial magnetic stimulation on patients with schizophrenia [J]. , 2020, 40(1): 81-. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||